President And Ceo, Biolargo, Inc

The following excerpt is from the company's SEC filing.

888-400-2863

Safe Harbor Act

– caution

regarding forward looking statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo’s (the “Company”) expectations regarding the impact of the COVID-19 pandemic; anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. R isks and uncertainties include without limitation: the effect of the COVID-19 pandemic on the Company’s business, results of operations, financial condition, and stock price; the effect of regional economic conditions on the Company’s business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company’s products. More information on these risks and other potential factors that could affect the Company’s business and financial results is included in the Company’s filings with the SEC, including in the “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of the Company’s most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever BIOLARGO, INC. makes a similar move, sign up!

Other recent filings from the company include the following:

Major owner of BIOLARGO, INC. just picked up 61,842 shares - Oct. 6, 2021
BIOLARGO, INC. director was just granted 98,684 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 98,684 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 78,947 options - Oct. 5, 2021
BIOLARGO, INC. director was just granted 78,947 options - Oct. 5, 2021

Auto Refresh

Feedback